Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple cellular pathways and processes is a non-specific descriptor rather than a defined molecular target such as a receptor, enzyme, or ion channel. In the context of pharmacology and drug development, a therapeutic target is typically a discrete biological entity whose activity can be modulated to achieve a clinical effect (Nature Reviews Drug Discovery, 2006). This term is often used in literature to describe the pleiotropic effects of a compound or the broad systemic impact of a treatment, but it lacks the specificity required for target-based drug design. Because it encompasses a wide range of disparate biological activities rather than a specific entity, it cannot be classified under standard molecular families or linked to a singular mechanism of action. Consequently, it is considered an incorrect or overly broad designation for a therapeutic target, as it fails to identify the specific protein or nucleic acid responsible for the observed pharmacological response. Analysts should seek to identify the specific molecular components, such as individual kinases or transcription factors, to accurately model drug-target interactions.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular pathways and processes.